USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
ABEOME CORPORATION
Address:
GEORGIA BIOBUSINESS CTR
ATHENS, GA 30605-2613
Phone:
(706) 542-7889
URL:
EIN:
158258827
DUNS:
095542358
Number of Employees:
2
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $609,911.00 4

Award List:

Novel Caenorhabditis Elegans Reagents

Award Year / Program / Phase:
2004 / SBIR / Phase I
Award Amount:
$100,000.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): C. elegans is well established as a highly useful model organism. The 14th annual Biennial International C. elegans Conference held June 29th-July 3, 2003 elicited over 1151 abstracts published by over 2500 authors. In the 1980s, complete descriptions of the… More

Novel Markers on Human Embryonic Stem Cells

Award Year / Program / Phase:
2004 / SBIR / Phase I
Award Amount:
$100,000.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION(provided by applicant): Embryonic stem cells (ES) are a major focus of research, because of their experimental utility and great promise as therapeutic tissue regeneration and gene replacement agents. ES cells are rapidly growing pluripotent cells with the capacity to differentiate into… More

Development of a transgenic mouse line engineered to permit selection and cloning

Award Year / Program / Phase:
2010 / SBIR / Phase I
Award Amount:
$133,995.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): The Applicant proposes an improvement to monoclonal antibody technology through the generation of transgenic mice engineered to facilitate flow cytometric isolation and cloning of specific antigen-reactive plasmacytes. Monoclonal antibodies (mAbs) are arguably… More

Development of a TAVI Device with a Reduced Crossing Profile

Award Year / Program / Phase:
2013 / SBIR / Phase I
Award Amount:
$275,916.00
Agency:
HHS
Principal Investigator:
Richard A. Shimkets – 706-542-7889
Abstract:
DESCRIPTION (provided by applicant): Obesity is considered the number one health problem in the US and Europe, affecting 10% to 30% of adult populations. Obese individuals are more likely to acquire a variety of secondary diseases including diabetes, heartproblems, immune deficiencies, some types of… More